acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

09 May 2023

Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System

New York and Washington (May 9, 2023) -- Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaborati...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 May 2023

Helen Ljungdahl Round, Acarix President & CEO presents at Redeye Investor Forum

On May 4th at 14.40 Helen Ljungdahl Round, Acarix President & CEO, presents the latest developments in the company at the Redeye In...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

02 May 2023

Acarix to present at the 2023 Aktiespararna Share Day in Stockholm

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that the company will present at the 2023 Aktiespararna Share ...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...

Continue reading

acarix

Annual, English, IR, Listing Regulation, News, Regulatory, Report

November 18, 2024

20 Apr 2023

Acarix AB’s Annual Report 2022

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory

November 18, 2024

11 Apr 2023

Notice of Annual General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on T...

Continue reading

acarix

Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares

November 18, 2024

04 Apr 2023

Acarix carries out a directed share issue amounting to approximately SEK 9.5 million

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, ...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 Apr 2023

Acarix accelerates US commercialization into 30 additional states

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

14 Mar 2023

Study published in Heart strengthens diagnostic value of Acarix CADScor System

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced the release of a new study published in the March 2023 i...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

06 Mar 2023

Acarix presents at Redeye: Commercialization Seminar

On March 7 at 10.30 CET Helen Ljungdahl Round, CEO of Acarix, presents the latest developments in the company at Redeye.The presentatio...

Continue reading

acarix

Corporate Information, English, IR, News, Other Corporate Information

November 18, 2024

03 Mar 2023

Acarix to showcase at the 2023 ACC congress

Acarix, a leader in acoustic and AI-based cardiac diagnostics, will demonstrate the value of its CADScor System during the American Col...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

21 Feb 2023

Acarix receives breakthrough order from US Veterans Health Administration

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati...

Continue reading